Higher-Risk
Showing 26 - 50 of >10,000
Colorectal Cancer Trial in New York (SBIRT, Referral as Usual (RAU))
Not yet recruiting
- Colorectal Cancer
- SBIRT
- Referral as Usual (RAU)
-
New York, New YorkColumbia University Medical Center
Dec 13, 2021
MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Sabatolimab
- +2 more
- (no location specified)
Sep 2, 2022
MDS Trial (Pevonedistat, Azacitidine)
No longer available
- Myelodysplastic Syndromes
- (no location specified)
Sep 8, 2021
Assess Occurrence of HPA-1a Alloimmunization in Higher Risk for
Recruiting
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Clinical data collection
-
Chandler, Arizona
- +5 more
Apr 19, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome
- ASP7517
-
Duarte, California
- +15 more
Jan 19, 2023
Prostate Cancer Trial in Sutton (Active Surveillance)
Not yet recruiting
- Prostate Cancer
- Active Surveillance
-
Sutton, Surrey, United KingdomInstitute of Cancer Research and Royal Marsden Hospital
Apr 11, 2023
Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)
Recruiting
- Chronic Myeloid Leukemia
- Myelofibroses
-
Chicago, IllinoisThe University of Chicago
May 16, 2022
Venous Thromboembolism and Bleeding Events inPopulation of Obese
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Health Behavior Trial in Salt Lake City (SomaSignal Test Results)
Recruiting
- Health Behavior
- SomaSignal Test Results
-
Salt Lake City, UtahIntermountain Medical Center
Aug 30, 2021
Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)
Recruiting
- Acute Leukemia
- +3 more
- 3D189
-
Guangzhou, Guangdong, China
- +3 more
Jan 2, 2023
Acute Myeloid Leukemia, MDS Trial in United States (CG-806)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +9 more
Mar 4, 2022
Sleep, Gut Microbiome, Cardiometabolic Risk Trial in Singapore (Dietary protein)
Not yet recruiting
- Sleep
- +2 more
- Dietary protein
-
Singapore, SingaporeNational University of Singapore
Sep 27, 2022
Hypercholesterolemia, Obesity, Diabetes Trial (smartphone health application (Opulse))
Not yet recruiting
- Hypercholesterolemia
- +3 more
- smartphone health application (Opulse)
- (no location specified)
Mar 23, 2023
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,
Terminated
- Myelodysplastic Syndromes (MDS)
- +2 more
- NEX-18a injection
- Azacitidine Injection
-
Huddinge, Sweden
- +1 more
Apr 4, 2022
Diabetes, Type 2 Trial in Atlanta (SomaSignal Informed Medical Management SSCVD, Standard of Care)
Recruiting
- Diabetes Mellitus, Type 2
- SomaSignal Informed Medical Management SSCVD
- Standard of Care
-
Atlanta, Georgia
- +4 more
Feb 15, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New Haven, Connecticut
- +23 more
Aug 1, 2022
TruGraf® Testing in High-Risk Kidney Transplant Recipients
Terminated
- Kidney Transplant Rejection
- TruGraf® Testing
-
Houston, TexasHouston Methodist Research Institute
Aug 26, 2021
MDS Trial in Tianjin (IBI188+azacitidine, Drug:Azacitidine)
Recruiting
- Myelodysplastic Syndromes
-
Tianjin, ChinaBlood Diseases Hospital Chinese Academy Of Medical Science
Mar 9, 2021
Cardiac Surgery, Sternal Wound Infection Trial in United States (gentamicin-collagen sponge dipped in saline)
Completed
- Cardiac Surgery
- Sternal Wound Infection
- gentamicin-collagen sponge dipped in saline
-
Birmingham, Alabama
- +42 more
May 4, 2022
Myelodysplastic Syndrome Trial in Suzhou (AK117, Azacitidine)
Recruiting
- Myelodysplastic Syndrome
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 21, 2021
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Bisantrene Dihydrochloride (high dose)
- +3 more
-
Newcastle, New South Wales, AustraliaCalvary Mater
Jul 14, 2022